Functional genomic analyses of the gut microbiota for crc screening

Nature Reviews Gastroenterology and Hepatology

Volumn 10, Issue 12, 2013, Pages 741-745

  Konstantinov, Sergey R ^a   Kuipers, Ernst J ^a   Peppelenbosch, Maikel P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM; COLORECTAL TUMOR; GASTROINTESTINAL TRACT; GENOMICS; HUMAN; INTESTINE; INTESTINE FLORA; MICROBIOLOGY; MICROFLORA;

BACTERIA; COLORECTAL NEOPLASMS; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; GENOMICS; HUMANS; INTESTINES; MICROBIOTA;

EID: 84979797034     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2013.178     Document Type: Article

References (45)

1. Herrinton, L. J. et al. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology 143, 382-389 (2012).
2. Schneider, E. B. et al. Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors. J. Am. Coll.Surg. 214, 390-398 (2012).
3. Hooper, L. V., Littman, D. R. & Macpherson, A. J. Interactions between the microbiota and the immune system. Science 336, 1268-1273 (2012).
4. Arthur, J. C. et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338, 120-123 (2012).
5. de Vos, W. M. & de Vos, E. A. Role of the intestinal microbiome in health and disease:from correlation to causation. Nutr. Rev. 70 (Suppl. 1), S45-S56 (2012).
6. Sokol, H. et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl Acad. Sci. USA 105, 16731-16736 (2008).
7. Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous clostridium species. Science 331, 337-341 (2011).
8. Grivennikov, S. I. et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491, 254-258 (2012).
9. Kusters, J., van Vliet, A. & Kuipers, E. J. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 19, 449-490 (2006).
10. Rajilic-Stojanovic, M., Shanahan, F., Guarner, F. & de Vos, W. Phylogenetic analysis of dysbiosis in ulcerative colitis during remission. Inflamm. Bowel Dis. 19, 481-488 (2013).
11. Balish, E. & Warner, T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am. J. Pathol. 160, 2253-2257 (2002).
12. Wang, X. et al. β-hydroxy-2-nonenal mediates genotoxicity and bystander effects caused by Enterococcus faecalis-infected macrophages. Gastroenterology 142, 543-551. (2012).
13. Darfeuille-Michaud, A. et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterology 127, 412-421 (2004).
14. Martin, H. M. et al. Enhanced Escherichia coli adherence and invasion in Crohn’s disease and colon cancer. Gastroenterology 127, 80-93 (2004).
15. Kostic, A. D. et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292-298 (2012).
16. Castellarin, M. et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22, 299-306 (2012).
17. Dharmani, P., Strauss, J., Ambrose, C., Allen-Vercoe, E. & Chadee, K. Fusobacterium nucleatum infection of colonic cells stimulates MUC2 mucin and tumor necrosis factor alpha. Infect. Immun. 79, 2597-2607 (2011).
18. Strauss, J. et al. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm. Bowel Dis. 17, 1971-1978 (2011).
19. Lepage, P. et al. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 141, 227-236 (2011).
20. Okin, D. & Medzhitov, R. Evolution of inflammatory diseases. Curr. Biol. 22, R733-R740 (2012).
21. Konstantinov, S. R. et al. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc. Natl Acad. Sci. USA 105, 19474-19479 (2008).
22. Grangette, C. et al. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc. Natl Acad. Sci. USA 102, 10321-10326 (2005).
23. Mohamadzadeh, M. et al. Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc. Natl Acad. Sci. USA 108, 4623-4630 (2011).
24. Fernandez, E. M. et al. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut 60, 1050-1059 (2011).
25. Lebeer, S., Claes, I. J. J., Verhoeven, T. L. A., Vanderleyden, J. & De Keersmaecker, S. C. J. Exopolysaccharides of Lactobacillus rhamnosus GG form a protective shield against innate immune factors in the intestine. Microb. Biotech. 4, 368-374 (2011).
26. Klaenhammer, T. R., Kleerebezem, M., Kopp, M. V. & Rescigno, M. The impact of probiotics and prebiotics on the immune system. Nat. Rev. Immunol. 12, 728-734 (2012).
27. Tsilingiri, K. et al. Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model. Gut 61, 1007-1015 (2012).
28. Yan, F. et al. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132, 562 (2007).
29. Yan, F. et al. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J. Clin. Invest. 121, 2242-2253 (2011).
30. Escamilla, J., Lane, M. A. & Maitin, V. Cell-free supernatants from probiotic Lactobacillus casei and Lactobacillus rhamnosus GG decrease colon cancer cell invasion in vitro. Nutr. Cancer 64, 871-878 (2012).
31. Khazaie, K. et al. Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc. Natl Acad. Sci. USA 109, 10462-10467 (2012).
32. Gounaris, E. et al. T-regulatory cells shift from a protective anti-inflammatory to a cancer- promoting proinflammatory phenotype in polyposis. Cancer Res. 69, 5490-5497 (2009).
33. Chen, C.-C. et al. Oral inoculation of probiotics Lactobacillus acidophilus NCFM suppresses tumour growth both in segmental orthotopic colon cancer and extraintestinal tissue. Br. J. Nutr. 107 1623-1634 (2012).
34. Schloissnig, S. et al. Genomic Variation landscape of the human gut microbiome. Nature 493, 45-50 (2013).
35. Ou, J. et al. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am. J. Clin. Nutr. http://dx.doi.org/10.3945/aicn.112.056689.
36. Degirolamo, C., Modica, S., Palasciano, G. & Moschetta, A. Bile acids and colon cancer: solving the puzzle with nuclear receptors. Trends Mol. Med. 17, 564-572 (2011).
37. Karlsson, F. H. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99-103 (2013).
38. Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60 (2012).
39. Nyangale, E. P., Mottram, D. S. & Gibson, G. R. Gut microbial activity, implications for health and disease: the potential role of metabolite analysis. J. Proteome Res. 11, 5573-5585 (2012).
40. Round, J. L. & Mazmanian, S. K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl Acad. Sci. USA 107, 12204-12209 (2010).
41. Surana, N. K. & Kasper, D. L. The yin-yang of bacterial polysaccharides: lessons learned from B. fragilis PSA. Immunol. Rev. 245, 13-26 (2012).
42. Fanning, S. et al. Bifidobacterial surface- exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc. Natl Acad. Sci. USA 109, 2108-2113 (2012).
43. Ewaschuk, J. B. et al. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G1025-G1034 (2008).
44. Ivanov, D. et al. A serpin from the gut bacterium Bifidobacterium longum inhibits eukaryotic elastase-like serine proteases. J. Biol. Chem. 281, 17246-17252 (2006).
45. Rafter, J. et al. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr. 85, 488-496 (2007).